CN101896457A - 组蛋白脱乙酰基酶抑制剂 - Google Patents

组蛋白脱乙酰基酶抑制剂 Download PDF

Info

Publication number
CN101896457A
CN101896457A CN2008801201496A CN200880120149A CN101896457A CN 101896457 A CN101896457 A CN 101896457A CN 2008801201496 A CN2008801201496 A CN 2008801201496A CN 200880120149 A CN200880120149 A CN 200880120149A CN 101896457 A CN101896457 A CN 101896457A
Authority
CN
China
Prior art keywords
oxoprop
phenyl
cyclopropylamino
fluorophenyl
acrylamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2008801201496A
Other languages
English (en)
Chinese (zh)
Inventor
斯里德哈兰·拉加戈帕尔
维兰德拉·卡扎迪亚
萨纳赛卡兰·庞潘迪安
阿卜杜尔·拉黑姆·克里
卡纳穆巴拉姆·阿南德汉
斯里拉姆·拉加戈帕尔
拉贞德兰·普拉维恩
普拉布胡·黛瓦斯加玛尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orchid Research Laboratories Ltd
Original Assignee
Orchid Research Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Research Laboratories Ltd filed Critical Orchid Research Laboratories Ltd
Publication of CN101896457A publication Critical patent/CN101896457A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/44—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN2008801201496A 2007-10-22 2008-10-21 组蛋白脱乙酰基酶抑制剂 Pending CN101896457A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN2384/CHE/2007 2007-10-22
IN2384CH2007 2007-10-22
IN980CH2008 2008-04-21
IN980/CHE/2008 2008-04-21
PCT/IB2008/002799 WO2009053808A2 (fr) 2007-10-22 2008-10-21 Inhibiteurs d'histone désacétylase

Publications (1)

Publication Number Publication Date
CN101896457A true CN101896457A (zh) 2010-11-24

Family

ID=40580150

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801201496A Pending CN101896457A (zh) 2007-10-22 2008-10-21 组蛋白脱乙酰基酶抑制剂

Country Status (14)

Country Link
US (1) US8450525B2 (fr)
EP (1) EP2209765A4 (fr)
JP (1) JP2011500783A (fr)
KR (1) KR20100074288A (fr)
CN (1) CN101896457A (fr)
AU (1) AU2008315651B2 (fr)
BR (1) BRPI0817860A2 (fr)
CA (1) CA2703231A1 (fr)
IL (1) IL205241A0 (fr)
MX (1) MX2010004402A (fr)
NZ (1) NZ584845A (fr)
RU (1) RU2453536C2 (fr)
WO (1) WO2009053808A2 (fr)
ZA (1) ZA201002841B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106977425A (zh) * 2017-04-01 2017-07-25 清华大学深圳研究生院 具有dna甲基转移酶和组蛋白去乙酰化酶抑制活性的异羟肟酸衍生物及其制备方法与应用
CN109476605A (zh) * 2016-07-18 2019-03-15 意大发马克股份公司 具有抗肿瘤活性的苯并-n-羟基酰胺化合物
WO2020011209A1 (fr) * 2018-07-11 2020-01-16 上海和誉生物医药科技有限公司 Agent immunosuppresseur, son procédé de préparation et son utilisation pharmaceutique
CN113461602A (zh) * 2021-07-07 2021-10-01 北京华氏信华科生物科技有限公司 具有hdac抑制活性的苯胺类化合物、制备方法、组合物及应用
CN115403483A (zh) * 2021-07-02 2022-11-29 河南省儿童医院郑州儿童医院 含二苯乙烯或二苯甲酮骨架的ca-4衍生物、药物组合物及其制备方法和应用

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8999289B2 (en) 2005-03-22 2015-04-07 President And Fellows Of Harvard College Treatment of protein degradation disorders
EP2133334A1 (fr) * 2008-06-09 2009-12-16 DAC S.r.l. Dérivés hétéroclites en tant qu'inhibiteurs HDAC
AU2009274549B2 (en) 2008-07-23 2014-05-01 Dana-Farber Cancer Institute, Inc. Deacetylase inhibitors and uses thereof
AU2009289649B2 (en) 2008-09-03 2016-05-05 Biomarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
WO2011019393A2 (fr) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Inhibiteurs de hdac classe- et isoforme-spécifiques et utilisations de ceux-ci
US20130040998A1 (en) * 2010-01-08 2013-02-14 Dana-Farber Cancer Institute, Inc. Fluorinated hdac inhibitors and uses thereof
US9540395B2 (en) 2011-02-28 2017-01-10 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2012117421A1 (fr) * 2011-03-02 2012-09-07 Orchid Research Laboratories Ltd Inhibiteurs de l'histone désacétylase
CA2834548C (fr) 2011-04-28 2021-06-01 The Broad Institute, Inc. Inhibiteurs de l'histone desacetylase
HK1200809A1 (en) * 2011-12-29 2015-08-14 药品循环有限责任公司 Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8
EP2877444B1 (fr) 2012-07-27 2020-09-02 The Broad Institute, Inc. Inhibiteurs d'histone-désacétylases
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
DK2970139T3 (en) 2013-03-15 2018-08-13 Biomarin Pharm Inc HDAC inhibitors
US10478431B2 (en) 2014-11-26 2019-11-19 The J. David Gladstone Institutes Methods for treating a cytomegalovirus infection
KR20180022840A (ko) * 2015-07-02 2018-03-06 바이오마린 파머수티컬 인크. 히스톤 데아세틸라제 저해제
CN109496210A (zh) 2016-07-26 2019-03-19 费森尤斯卡比肿瘤学有限公司 贝利司他的多晶型及其制备方法
EP3737362B1 (fr) 2018-01-12 2025-10-15 Kdac Therapeutics, Inc. Combinaison d'un inhibiteur sélectif de désacétylase d'histone 3 (hdac3) et d'un agent d'immunothérapie pour le traitement du cancer
WO2019241435A1 (fr) 2018-06-12 2019-12-19 The J. David Gladstone Institutes Compositions pour interruption de circuit de rétroaction transcriptionnelle de virus de l'herpès et utilisations correspondantes
US20220154282A1 (en) 2019-03-12 2022-05-19 The Broad Institute, Inc. Detection means, compositions and methods for modulating synovial sarcoma cells
US20230285331A1 (en) * 2022-01-24 2023-09-14 University Of South Carolina Tyrosine and resveratrol derivatives as novel modulators of cellular serine-adp-ribosylation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578498A (en) * 1982-01-23 1986-03-25 Basf Aktiengesellschaft Phenylethylene derivatives and their use as drugs
US4808597A (en) * 1983-07-05 1989-02-28 Pfizer Inc. Method for inhibiting the degradation of cartilage
US5489611A (en) * 1995-02-10 1996-02-06 Warner-Lambert Company Method for lowering plasma levels of lipoprotein (a)
WO2007005568A1 (fr) * 2005-06-30 2007-01-11 Wisconsin Alumni Research Foundation Analogues d'acide 4-[(e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtalenyl)-1-propenyl]benzoique et procede de production et d'utilisation de ceux-ci
CN101312940A (zh) * 2005-11-17 2008-11-26 伊莱利利公司 胰高血糖素受体拮抗剂、制备和治疗用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85558A1 (fr) * 1984-09-28 1986-04-03 Oreal Nouveaux derives naphtaleniques a action retinoique,leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
DK0403159T3 (da) * 1989-06-14 2000-08-14 Smithkline Beecham Corp Imidazolylalkensyrer
GB9110532D0 (en) * 1991-05-15 1991-07-03 Smithkline Beecham Corp Chemical compounds
US5369108A (en) * 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
US5187188A (en) * 1992-04-03 1993-02-16 Bristol-Myers Squibb Company Oxazole carboxylic acid derivatives
TW419461B (en) * 1993-06-16 2001-01-21 Bristol Myers Squibb Co Alicyclic phospholipase A2 inhibitors
US5416089A (en) * 1993-06-24 1995-05-16 The Du Pont Merck Pharmaceutical Company Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
CA2266556C (fr) * 1996-09-30 2007-11-06 Hoechst Marion Roussel, Inc. Antagonistes du nmda (n-methyl-d-aspartate)
WO1998032741A1 (fr) * 1997-01-29 1998-07-30 Zeneca Limited Inhibiteurs de farnesyl proteine transferase
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.
JPH10287634A (ja) * 1997-04-11 1998-10-27 Otsuka Pharmaceut Co Ltd ベンゼン誘導体
AUPO721997A0 (en) 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
AU2435199A (en) * 1998-02-10 1999-08-30 Astrazeneca Uk Limited Farnesyl transferase inhibitors
US6624197B1 (en) * 1998-05-08 2003-09-23 Calyx Therapeutics, Inc. Diphenylethylene compounds
EP1748046A3 (fr) 1999-11-23 2007-08-22 Methylgene, Inc. Inhibiteurs d'histone déacetylase
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
JP4975941B2 (ja) * 2000-09-29 2012-07-11 トポターゲット ユーケー リミテッド （ｅ）−ｎ−ヒドロキシ−３−（３−スルファモイル−フェニル）アクリルアミド化合物及びその治療用途
CN101851173A (zh) * 2001-09-14 2010-10-06 梅特希尔基因公司 组蛋白脱乙酰化酶抑制剂
US7868204B2 (en) * 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
AU2003273701A1 (en) * 2002-10-17 2004-05-04 Methylgene Inc. Inhibitors of histone deacetylase
DE60336850D1 (en) * 2003-01-06 2011-06-01 Lilly Co Eli Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
US7244751B2 (en) * 2003-02-14 2007-07-17 Shenzhen Chipscreen Biosciences Ltd. Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
US20050038125A1 (en) * 2003-08-15 2005-02-17 Smit Hobbe Friso Method for the treatment of arthritis and pain
EP1677731A4 (fr) * 2003-10-09 2009-05-06 Aton Pharma Inc Derives thiophene et benzothiophene d'acide hydroxamique
CN101010298A (zh) * 2004-04-05 2007-08-01 默克Hdac研究有限责任公司 组蛋白脱乙酰酶抑制剂前药
GB2427405A (en) * 2004-04-07 2006-12-27 Pharmacyclics Inc Novel hydroxamates as therapeutic agents
WO2005121073A1 (fr) * 2004-06-10 2005-12-22 Cancer Research Technology Limited Inhibiteur de l'histone desacetylase
EP1767530A4 (fr) * 2004-07-07 2007-06-13 Kyoyu Agri Co Ltd Benzoxazoles
KR100686531B1 (ko) * 2004-08-31 2007-02-23 한국화학연구원 히스톤 디아세틸라제 저해활성을 갖는 아릴아미노메틸프로페닐 벤즈하이드록시아마이드 유도체 및 그의 제조방법
KR100696139B1 (ko) * 2005-11-01 2007-03-20 한국화학연구원 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시 옥테노일 하이드록시아마이드 유도체 및그의 제조방법
AU2007286146A1 (en) * 2006-08-11 2008-02-21 Methylgene Inc. Potentiation of antifungal compounds
JP5277171B2 (ja) 2006-11-03 2013-08-28 コリア リサーチ インスティテュート オブ ケミカル テクノロジーズ ヒストン脱アセチル化酵素阻害活性を有するナフタレニルオキシプロペニル誘導体およびこれを含む薬学組成物
JP2009051735A (ja) * 2007-08-23 2009-03-12 Kyoyu Agri Kk ベンゾオキサゾール誘導体
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578498A (en) * 1982-01-23 1986-03-25 Basf Aktiengesellschaft Phenylethylene derivatives and their use as drugs
US4808597A (en) * 1983-07-05 1989-02-28 Pfizer Inc. Method for inhibiting the degradation of cartilage
US5489611A (en) * 1995-02-10 1996-02-06 Warner-Lambert Company Method for lowering plasma levels of lipoprotein (a)
WO2007005568A1 (fr) * 2005-06-30 2007-01-11 Wisconsin Alumni Research Foundation Analogues d'acide 4-[(e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtalenyl)-1-propenyl]benzoique et procede de production et d'utilisation de ceux-ci
CN101312940A (zh) * 2005-11-17 2008-11-26 伊莱利利公司 胰高血糖素受体拮抗剂、制备和治疗用途

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109476605A (zh) * 2016-07-18 2019-03-15 意大发马克股份公司 具有抗肿瘤活性的苯并-n-羟基酰胺化合物
CN109476605B (zh) * 2016-07-18 2022-05-31 意大发马克股份公司 具有抗肿瘤活性的苯并-n-羟基酰胺化合物
CN106977425A (zh) * 2017-04-01 2017-07-25 清华大学深圳研究生院 具有dna甲基转移酶和组蛋白去乙酰化酶抑制活性的异羟肟酸衍生物及其制备方法与应用
WO2020011209A1 (fr) * 2018-07-11 2020-01-16 上海和誉生物医药科技有限公司 Agent immunosuppresseur, son procédé de préparation et son utilisation pharmaceutique
CN111886219A (zh) * 2018-07-11 2020-11-03 上海和誉生物医药科技有限公司 免疫抑制剂及其制备方法和在药学上的应用
CN111886219B (zh) * 2018-07-11 2023-04-25 上海和誉生物医药科技有限公司 免疫抑制剂及其制备方法和在药学上的应用
CN115403483A (zh) * 2021-07-02 2022-11-29 河南省儿童医院郑州儿童医院 含二苯乙烯或二苯甲酮骨架的ca-4衍生物、药物组合物及其制备方法和应用
CN115403483B (zh) * 2021-07-02 2024-01-26 河南省儿童医院郑州儿童医院 含二苯乙烯或二苯甲酮骨架的ca-4衍生物、药物组合物及其制备方法和应用
CN113461602A (zh) * 2021-07-07 2021-10-01 北京华氏信华科生物科技有限公司 具有hdac抑制活性的苯胺类化合物、制备方法、组合物及应用

Also Published As

Publication number Publication date
RU2453536C2 (ru) 2012-06-20
BRPI0817860A2 (pt) 2019-09-24
CA2703231A1 (fr) 2009-04-30
IL205241A0 (en) 2010-12-30
WO2009053808A3 (fr) 2010-07-01
MX2010004402A (es) 2010-10-15
RU2010120682A (ru) 2011-11-27
EP2209765A2 (fr) 2010-07-28
ZA201002841B (en) 2010-12-29
US8450525B2 (en) 2013-05-28
US20100291003A1 (en) 2010-11-18
NZ584845A (en) 2011-09-30
AU2008315651A1 (en) 2009-04-30
EP2209765A4 (fr) 2010-12-01
KR20100074288A (ko) 2010-07-01
WO2009053808A2 (fr) 2009-04-30
JP2011500783A (ja) 2011-01-06
AU2008315651B2 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
CN101896457A (zh) 组蛋白脱乙酰基酶抑制剂
US20110212943A1 (en) Novel bridged cyclic compounds as histone deacetylase inhibitors
Chen et al. Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors
JP2014144947A (ja) 新規ヒストンデアセチラーゼインヒビター
Gong et al. Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy
JP6043298B2 (ja) Ｔｒｐｍ８受容体アンタゴニスト
HRP970637A2 (en) New benzamidoaldehydes and their use
JP2009242437A (ja) スルホンアミド誘導体
BR112013032306B1 (pt) derivados de indanona, método de preparação dos mesmos, composições farmacêuticas e uso dos mesmos para prevenção ou tratamento de doenças virais
WO2023097386A1 (fr) Composés n-acylhydrazoniques inhibiteurs sélectifs de hdac6, leurs procédés d'obtention, compositions, utilisations, méthodes de traitement et trousses
WO2010073078A2 (fr) Composés hétérocycliques comme inhibiteurs de hdac
WO2008087514A2 (fr) Inhibiteurs d'hdac
JP2022528109A (ja) キノリル含有化合物、医薬組成物およびその使用
EP3844152A1 (fr) Hétérocycles substitués servant d'agents de ciblage de c-myc
KR20100132553A (ko) 신규한 ｎ-(2-아미노-페닐)-아크릴아미드
ES2354979T3 (es) Derivado de tacrina como inhibidores de acetilcolinesterasa.
CN110734391A (zh) 2,3-二酮吲哚类化合物及其制备方法与应用
CN104592114A (zh) 取代喹啉类组蛋白去乙酰化酶抑制剂及制备方法和应用
CN118084732A (zh) 靶向5-htt/hdac双靶点的抑制剂及其制备方法和应用
CN109096178B (zh) 用于治疗癌症的苯乙炔基取代苯和杂环及其应用
KR100632800B1 (ko) 히스톤 디아세틸라제 저해활성을 갖는 신규한하이드록시아마이드 유도체 및 이의 제조 방법
KR100584811B1 (ko) 히스톤 디아세틸라제 저해활성을 갖는ｎ,ｎ-다이메틸아미노페닐 옥타노산 하이드록시아마이드유도체 및 이의 제조방법
CN121974826A (en) Iron death/HDAC 6 dual-function inhibitor and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20101124

C20 Patent right or utility model deemed to be abandoned or is abandoned